Table 3. Odds ratio of signs and symptoms in confirmed mpox cases in women compared with men, adjusted by sexual transmission mechanism, Spain, 26 April–21 November 2022 (n = 7,040).

Signs and symptoms	OR (non-adjusted)		OR (adjusted)^a
Signs and symptoms	OR (95% CI)	p value	OR (95% CI)	p value
General symptoms	0.95 (0.65–1.37)	0.770	0.92 (0.72–1.18)	0.721
Anogenital exanthema	0.51 (0.37–0.70)	< 0.001	0.56 (0.45–0.69)	< 0.001
Oral exanthema	0.87 (0.57–1.34)	0.530	0.84 (0.39–0.73)	0.725
Other exanthemas	1.72 (1.21–2.45)	0.002	2.20 (1.74–2.77)	< 0.001
Local lymphadenopathies	0.89 (0.65–1.23)	0.497	0.97 (0.68–1.39)	0.686
Generalised lymphadenopathies	0.72 (0.32–1.65)	0.417	0.46 (0.25–0.83)	0.009

CI: confidence interval; OR: odds ratio.

^a Multivariate logistic regression was performed to adjust measured OR by transmission mechanism.